The consolidated net profit of Jubilant Life Sciences increased only by 2 per cent to Rs.152 crore in the fourth quarter ended March 2018 from Rs.149 crore due to significant higher provision for taxation of Rs.74
More From BioPortfolio on "Higher taxation impacts net profit of Jubilant Life in Q4, investing Rs.550 cr on expansion"